Whether or not combined with ACE-inhibitors, excessive soluble rhACE2 could be a potential therapeutic strategy to counteract unescapably unrestrained ACE activity to contrast SARS coronavirus-induced lung injury and ARDS.30,45. Here, ACE is linked to acute respiratory distress syndrome.